← back to search

Norbert Mages

Max Planck Institute for Molecular Genetics · DE
Area of research
Infectious Diseases · Pathology and Forensic Medicine
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Systemic Sclerosis and Related Diseases, COVID-19 Clinical Research Studies, and Immunotherapy and Immune Responses.
h-index
4
citations
186
works
12
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
European Journal of Immunology 2025cited by 1position: middledoi
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Frontiers in Immunology 2023cited by 8position: middledoi
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Nature Communications 2019cited by 98position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claudia Giesecke‐Thiel · Max Planck Institute for Molecular Genetics3 papers (2019–2025)Ulf Reimer · JPT Peptide Technologies (Germany)2 papers (2023–2025)— · 2 papers (2023–2025)— · 2 papers (2023–2025)Andreas Nitsche · Zuse Institute Berlin2 papers (2023–2025)Manuela Dingeldey · Berlin-Brandenburger Centrum für Regenerative Therapien2 papers (2023–2025)Julian Braun · Humboldt-Universität zu Berlin2 papers (2023–2025)Maike Mangold · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2023–2025)Karsten Jürchott · Charité - Universitätsmedizin Berlin2 papers (2023–2025)Larissa Henze · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2023–2025)Bernd Timmermann · Max Planck Institute for the Study of Societies2 papers (2023–2025)Beate Kruse · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2023–2025)Lucie Loyal · Siemens (Hungary)2 papers (2023–2025)Andreas Thiel · Martin Luther University Halle-Wittenberg2 papers (2023–2025)Lil Meyer‐Arndt · Max Delbrück Center2 papers (2023–2025)Janine Michel · European Molecular Biology Laboratory2 papers (2023–2025)Holger Wenschuh · JPT Peptide Technologies (Germany)2 papers (2023–2025)Florian Uhlitz · Immunai (United States)1 papers (2019–2019)Nils Blüthgen · German Cancer Research Center1 papers (2019–2019)Bernhard G. Herrmann · Charité - Universitätsmedizin Berlin1 papers (2019–2019)